|
SIKE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.46139997062534E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.81129999677188E-09 |
| Normal-vs-Stage2 |
4.313500E-02 |
| Normal-vs-Stage3 |
5.702300E-03 |
| Normal-vs-Stage4 |
9.034100E-02 |
| Stage1-vs-Stage2 |
3.568400E-01 |
| Stage1-vs-Stage3 |
2.263600E-01 |
| Stage1-vs-Stage4 |
3.749800E-01 |
| Stage2-vs-Stage3 |
9.317400E-01 |
| Stage2-vs-Stage4 |
8.752800E-01 |
| Stage3-vs-Stage4 |
9.034000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17690002188198E-09 |
| Normal-vs-AfricanAmerican |
1.777440E-03 |
| Normal-vs-Asian |
1.422850E-01 |
| Caucasian-vs-AfricanAmerican |
3.163200E-01 |
| Caucasian-vs-Asian |
8.956800E-01 |
| AfricanAmerican-vs-Asian |
8.175600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35520039634685E-10 |
| Normal-vs-Female |
1.889820E-02 |
| Male-vs-Female |
4.244800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.364170E-03 |
| Normal-vs-Extreme_Weight |
2.98010505161983E-11 |
| Normal-vs-Obese |
5.82350000000176E-05 |
| Normal-vs-Extreme_Obese |
6.574800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.181250E-01 |
| Normal_Weight-vs-Obese |
9.667400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.920200E-01 |
| Extreme_Weight-vs-Obese |
5.325900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.327400E-01 |
| Obese-vs-Extreme_Obese |
2.157000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.799600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.95839999997494E-06 |
| Normal-vs-Age(61-80Yrs) |
3.84109999362892E-09 |
| Normal-vs-Age(81-100Yrs) |
2.175300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.042600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.238000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.249700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.006570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.181610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34500197038301E-11 |
| Normal-VS-Type2 PRCC |
1.957620E-04 |
| Normal-VS-KIRP CIMP |
9.268000E-02 |
| Normal-VS-Unclassified PRCC |
1.223420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.943620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.865900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.866020E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.095800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.153400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.768600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.56959999944684E-07 |
| Normal-vs-N1 |
2.252500E-02 |
| Normal-vs-N2 |
1.950630E-01 |
| N0-vs-N1 |
1.288430E-01 |
| N0-vs-N2 |
8.716800E-01 |
| N1-vs-N2 |
4.233000E-01 |
|
|
